Subcutaneous Injection of Adalimumab Trial Compared With Control (SCIATiC): A Randomised Controlled Trial of Adalimumab Injection Compared With Placebo for Patients Receiving Physiotherapy Treatment for Sciatica

Health Technology Assessment - United Kingdom
doi 10.3310/hta21600
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National Institute for Health Research

Related search

Randomised Controlled Trial of Intravenous Antibiotic Treatment for Cellulitis at Home Compared With Hospital

BMJ
2004English

Arthroscopic Hip Surgery Compared With Physiotherapy and Activity Modification for the Treatment of Symptomatic Femoroacetabular Impingement: Multicentre Randomised Controlled Trial

British Medical Journal
Medicine
2019English

Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2015English

Percutaneous Regional Compared With Local Anaesthesia for Facial Lacerations: A Randomised Controlled Trial

Emergency Medicine Journal
MedicineCritical CareEmergency MedicineIntensive Care Medicine
2004English

Ultrasound Guided Corticosteroid Injection for Plantar Fasciitis: Randomised Controlled Trial

British Medical Journal
Medicine
2012English

Patient-Initiated Appointments Compared With Standard Outpatient Care for Rheumatoid Arthritis: A Randomised Controlled Trial

RMD Open
RheumatologyAllergyImmunology
2016English

OP0130 Mepolizumab for the Treatment of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomised, Placebo-Controlled Trial

2017English

Physiotherapy Breathing Retraining for Asthma: A Randomised Controlled Trial

Lancet Respiratory Medicine,The
PulmonaryRespiratory Medicine
2018English

Efficacy of Xuebijing Injection for Sepsis (EXIT-SEP): Protocol for a Randomised Controlled Trial

BMJ Open
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy